Undifferentiated pancreatic carcinoma

MONDO:0006478

A carcinoma with poor prognosis that arises from the pancreas. It is characterized by the presence of a significant malignant component that does not show differentiation. The malignant cells represent a mixture of large, pleomorphic cells and giant cells, or adenocarcinoma cells and spindle cells, or spindle cells.

Also known as: pancreas undifferentiated carcinoma, pancreatic carcinosarcoma, pleomorphic large cell pancreatic carcinoma, sarcomatoid pancreatic carcinoma, spindle cell pancreatic carcinoma, undifferentiated (anaplastic) pancreatic carcinoma, undifferentiated carcinoma of pancreas, undifferentiated carcinoma of the pancreas

2884 clinical trials for this condition and its sub-types, 1 tagged with Undifferentiated pancreatic carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Pancreatic ductal adenocarcinoma (553) ↑ Undifferentiated carcinoma (80)

Sub-types of Undifferentiated pancreatic carcinoma

Undifferentiated pancreatic carcinoma with osteoclast-like giant cells 0 trials

Including sub-types (2884) Tagged with Undifferentiated pancreatic carcinoma (1)

Trials to join now! 1

New chemo combo strategy aims to outsmart pancreatic cancer

Disease control Recruiting now

This phase 2 trial tests a new approach for people with metastatic pancreatic cancer: alternating two standard chemotherapy regimens every month instead of using just one. The goal is to see if this switching strategy can keep the cancer from growing for at least 6 months. About …

Phase 2 • Sponsor: Northwell Health • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC

Undifferentiated pancreatic carcinoma

Where it sits in the disease tree

New chemo combo strategy aims to outsmart pancreatic cancer